Clinical Trials in Nashville

Showing 6581-6600 of 20,298 trials

LEV102 Topical Gel in Acquired Blepharoptosis

NCT05715346

Phase 1/2a, multicenter, randomized, vehicle-controlled, double-masked, multiple-dose, parallel-group study conducted in adult subjects with acquired blepharoptosis.

Acquired Blepharoptosis

Levation Pharma, Ltd.33 participantsStarted Feb 2023

Newport Beach, California, United States • Newport Beach, California, United States • Nashville, Tennessee, United States

COMPLETEDNA< 1 mile

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

NCT03641677

The objective of this study is to evaluate the safety and effectiveness of the Centralized Lung Evaluation System (CLES) in enabling evaluation of potential donor lungs not otherwise used for transplant into subjects with end stage, survival-limiting lung disease in need of lung transplantation. This will be accomplished by evaluating subject survival at the later of 12 months or hospital discharge post-transplant.

Lung Diseases

Lung Bioengineering Inc.174 participantsStarted Jan 2019

Jacksonville, Florida, United States • Atlanta, Georgia, United States • Baltimore, Maryland, United States +10 more locations

LEV102 Topical Gel in Acquired Blepharoptosis

Increasing Lung Transplant Availability Using Normothermic Ex Vivo Lung Perfusion (EVLP) at a Dedicated EVLP Facility

Find Trials by Condition in Nashville

Carboplatin and Paclitaxel With or Without Vorinostat in Treating Patients With Advanced Non-Small Cell Lung Cancer

A Phase 1, Dose Escalation Study to Assess the Safety and Tolerability of ASP9853 With Either Docetaxel or Paclitaxel in Patients With Advanced Non-hematologic Malignancies

A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

Ganitumab in Locally Advanced Unresectable Adenocarcinoma of the Pancreas

Study of the Efficacy and Safety of Lemborexant in Subjects 55 Years and Older With Insomnia Disorder (SUNRISE 1)

Study of GSK3845097 in Previously Treated Participants With Advanced Synovial Sarcoma and Myxoid/Round Cell Liposarcoma

EnSite Precision Observational Study

Wound Assessment Using Spectral Imaging US

A Study of Ipatasertib Plus Palbociclib and Fulvestrant Versus Placebo Plus Palbociclib and Fulvestrant in Hormone Receptor Positive and HER2 Negative Locally Advanced Unresectable or Metastatic Breast Cancer

Lumateperone for the Prevention of Relapse in Patients With Schizophrenia

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK2798745 in Participants With Diabetic Macular Edema

Study to Investigate LP352 in Subjects With Developmental and Epileptic Encephalopathies

A Study to Evaluate ONM100, an Intraoperative Fluor Imaging Agent for the Detection of Peri Mets

De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca

Study to Evaluate the Safety, Tolerability,Pharmacokinetics, and Antitumor Activity of a Thorium-227 Labeled Antibody-chelator Conjugate Alone and in Combination With Darolutamide, in Patients With Metastatic Castration Resistant Prostate Cancer

Glyburide (RP-1127) for Traumatic Brain Injury (TBI)

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

A Study to Evaluate Pegsitacianine, an Intraoperative Fluorescence Imaging Agent for the Detection of Lung Malignancies